Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ArcelorMittal SA (MT) vs Tilray Brands Inc (TLRY) Price & Performance

ArcelorMittal SATrade
Tilray Brands IncTrade

Price performance (Past 24H)

Key statistics

ArcelorMittal SA vs Tilray Brands Inc — how do they compare? ArcelorMittal SA trades at $77.08 (market cap $58.51B), while Tilray Brands Inc trades at $4.21 (market cap $591.60M). The key difference: ArcelorMittal SA is far larger — about 98.9× Tilray Brands Inc's market cap, and ArcelorMittal SA pays a 0.78% dividend while Tilray Brands Inc pays none. Which is the better fit depends on your goals.

MTTLRY
Market Cap
$58.51B$591.60M
Sector
Basic MaterialsHealth
52-Week High
$78.74$21.00
52-Week Low
$34.39$3.88
Enterprise Value
$68.08B$758.73M
Dividend Yield
0.78%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ArcelorMittal SA

ArcelorMittal (MT) trades at $77.15, down 2.02% on the day, with a bullish technical signal from moving averages and a neutral RSI. The company reported mixed Q2 2026 earnings, missing EPS estimates but showing year-over-year sales growth. Recent news highlights expansion in steel capacity and strategic partnerships, while facing headwinds from weak Chinese demand and geopolitical risks in Ukraine. Cash flow trends show a narrowing net outflow, improving from 2023 levels.

The outlook is cautiously optimistic, supported by analyst consensus and European demand improvements, but risks from industry cyclicality and input cost pressures remain. Investment appeal hinges on execution of growth initiatives and macroeconomic stability in key markets.

Tilray Brands Inc

TLRY trades at $4.30, down 4.44% today, reflecting ongoing investor skepticism despite record fiscal 2026 revenue of $915 million. The stock shows bearish technical signals with key support at $4.00, while fundamentals reveal significant challenges including negative net income margins (-13.26%) and consecutive earnings misses. Recent developments include strategic partnerships expansion in New York and California spirits markets and increased medical cannabis production capacity to 275 metric tonnes.

TLRY faces substantial execution risks with persistent losses and negative cash flow, though trading below book value (P/B 0.37) offers potential value. Analyst consensus remains cautious with 65% hold ratings, while regulatory progress in cannabis remains a key catalyst. The stock requires successful margin improvement and U.S. regulatory clarity for sustained recovery.

Returns comparison

Trailing returns across standard periods

About ArcelorMittal SA

ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA

Read more on MT

About Tilray Brands Inc

Tilray is a Canadian company that grows and sells medical and recreational cannabis. In 2021, Aphria acquired Tilray in a reverse merger and adopted the Tilray name. Most of its sales come from Canada and international medical cannabis exports, while its U.S. business focuses on CBD products and alcohol.

Read more on TLRY